BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Efferth T, Saeed ME, Kadioglu O, Seo E, Shirooie S, Mbaveng AT, Nabavi SM, Kuete V. Collateral sensitivity of natural products in drug-resistant cancer cells. Biotechnology Advances 2020;38:107342. [DOI: 10.1016/j.biotechadv.2019.01.009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhao B, Li H, Su Y, Tian K, Zou Z, Wang W. Synthesis and Anticancer Activity of Bagasse Xylan/Resveratrol Graft-Esterified Composite Nanoderivative. Materials (Basel) 2022;15:5166. [PMID: 35897598 DOI: 10.3390/ma15155166] [Reference Citation Analysis]
2 Cuellar-vite L, Weber-bonk KL, Abdul-karim FW, Booth CN, Keri RA. Focal Adhesion Kinase Provides a Collateral Vulnerability That Can Be Leveraged to Improve mTORC1 Inhibitor Efficacy. Cancers 2022;14:3374. [DOI: 10.3390/cancers14143374] [Reference Citation Analysis]
3 Nchiozem-ngnitedem V, Omosa LK, Derese S, Efferth T, Spiteller M. Cytotoxic flavonoids from the seeds of Dracaena steudneri Engl against leukemia cancer cell lines. Phytomedicine Plus 2022;2:100234. [DOI: 10.1016/j.phyplu.2022.100234] [Reference Citation Analysis]
4 Saeed MEM, Yücer R, Dawood M, Hegazy MF, Drif A, Ooko E, Kadioglu O, Seo E, Kamounah FS, Titinchi SJ, Bachmeier B, Efferth T. In Silico and In Vitro Screening of 50 Curcumin Compounds as EGFR and NF-κB Inhibitors. IJMS 2022;23:3966. [DOI: 10.3390/ijms23073966] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Cao W, Tian R, Pan R, Sun B, Xiao C, Chen Y, Zeng Z, Lei S. Terpinen-4-ol inhibits the proliferation and mobility of pancreatic cancer cells by downregulating Rho-associated coiled-coil containing protein kinase 2. Bioengineered 2022;13:8643-56. [PMID: 35322742 DOI: 10.1080/21655979.2022.2054205] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Dong S, Guo X, Han F, He Z, Wang Y. Emerging role of natural products in cancer immunotherapy. Acta Pharm Sin B 2022;12:1163-85. [PMID: 35530162 DOI: 10.1016/j.apsb.2021.08.020] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Ihmaid SK, Aljuhani A, Alsehli M, Rezki N, Alawi A, Aldhafiri AJ, Salama SA, Ahmed HE, Aouad MR. Discovery of triaromatic flexible agents bearing 1,2,3-Triazole with selective and potent anti-breast cancer activity and CDK9 inhibition supported by molecular dynamics. Journal of Molecular Structure 2022;1249:131568. [DOI: 10.1016/j.molstruc.2021.131568] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
8 Barbosa MAG, Xavier CPR, Pereira RF, Petrikaitė V, Vasconcelos MH. 3D Cell Culture Models as Recapitulators of the Tumor Microenvironment for the Screening of Anti-Cancer Drugs. Cancers (Basel) 2021;14:190. [PMID: 35008353 DOI: 10.3390/cancers14010190] [Reference Citation Analysis]
9 Wang Q, Wang J, Wang J, Ju X, Zhang H. Molecular mechanism of shikonin inhibiting tumor growth and potential application in cancer treatment. Toxicol Res (Camb) 2021;10:1077-84. [PMID: 34956612 DOI: 10.1093/toxres/tfab107] [Reference Citation Analysis]
10 Xue P, Chen Q, Ren X, Liu D, Yang X. A novel protoapigenone analog RY10-4 induces apoptosis of breast cancer cells by exacerbating mitochondrial Ca2+ influx through mitochondrial calcium uniporter. Toxicol Appl Pharmacol 2021;433:115776. [PMID: 34717963 DOI: 10.1016/j.taap.2021.115776] [Reference Citation Analysis]
11 Zheng D, Chen S, Cai K, Lei L, Wu C, Sun C, Deng Y, Yu C. Prodigiosin inhibits cholangiocarcinoma cell proliferation and induces apoptosis via suppressing SNAREs-dependent autophagy. Cancer Cell Int 2021;21:658. [PMID: 34886869 DOI: 10.1186/s12935-021-02355-3] [Reference Citation Analysis]
12 Podolski-Renić A, Dinić J, Stanković T, Tsakovska I, Pajeva I, Tuccinardi T, Botta L, Schenone S, Pešić M. New Therapeutic Strategy for Overcoming Multidrug Resistance in Cancer Cells with Pyrazolo[3,4-d]pyrimidine Tyrosine Kinase Inhibitors. Cancers (Basel) 2021;13:5308. [PMID: 34771471 DOI: 10.3390/cancers13215308] [Reference Citation Analysis]
13 Sun X, Zhang Y, Zhou Y, Lian X, Yan L, Pan T, Jin T, Xie H, Liang Z, Qiu W, Wang J, Li Z, Zhu F, Sui X. NPCDR: natural product-based drug combination and its disease-specific molecular regulation. Nucleic Acids Res 2021:gkab913. [PMID: 34664659 DOI: 10.1093/nar/gkab913] [Reference Citation Analysis]
14 Vendramin R, Litchfield K, Swanton C. Cancer evolution: Darwin and beyond. EMBO J 2021;40:e108389. [PMID: 34459009 DOI: 10.15252/embj.2021108389] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Yu KH, Hung CC, Wu TS, Chen CF, Wu IT, Kuo PC, Lam SH, Hung HY. Chemoreversal Agents from Taiwanofungus Genus and Their More Potent Methyl Derivatives Targeting Signal Transducer and Activator of Transcription 3 (STAT3) Phosphorylation. Pharmaceuticals (Basel) 2021;14:916. [PMID: 34577615 DOI: 10.3390/ph14090916] [Reference Citation Analysis]
16 Pandey R, Bhairam M, Shukla SS, Gidwani B. Colloidal and vesicular delivery system for herbal bioactive constituents. Daru 2021. [PMID: 34327650 DOI: 10.1007/s40199-021-00403-x] [Reference Citation Analysis]
17 Zhang Z, Shi J, Nice EC, Huang C, Shi Z. The Multifaceted Role of Flavonoids in Cancer Therapy: Leveraging Autophagy with a Double-Edged Sword. Antioxidants (Basel) 2021;10:1138. [PMID: 34356371 DOI: 10.3390/antiox10071138] [Reference Citation Analysis]
18 Gutierrez C, Al'Khafaji AM, Brenner E, Johnson KE, Gohil SH, Lin Z, Knisbacher BA, Durrett RE, Li S, Parvin S, Biran A, Zhang W, Rassenti L, Kipps TJ, Livak KJ, Neuberg D, Letai A, Getz G, Wu CJ, Brock A. Multifunctional barcoding with ClonMapper enables high-resolution study of clonal dynamics during tumor evolution and treatment. Nat Cancer 2021;2:758-72. [PMID: 34939038 DOI: 10.1038/s43018-021-00222-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 15.0] [Reference Citation Analysis]
19 Sayed HM, Said MM, Morcos NYS, El Gawish MA, Ismail AFM. Antitumor and Radiosensitizing Effects of Zinc Oxide-Caffeic Acid Nanoparticles against Solid Ehrlich Carcinoma in Female Mice. Integr Cancer Ther 2021;20:15347354211021920. [PMID: 34105411 DOI: 10.1177/15347354211021920] [Reference Citation Analysis]
20 Yang S, Liu Y, Xiao Z, Tang Y, Hong P, Sun S, Zhou C, Qian Z. Inhibition effects of 7-phloro-eckol from Ecklonia cava on metastasis and angiogenesis induced by hypoxia through regulation of AKT/mTOR and ERK signaling pathways. Arabian Journal of Chemistry 2021;14:103187. [DOI: 10.1016/j.arabjc.2021.103187] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Safaei M, Shishehbore MR. A review on analytical methods with special reference to electroanalytical methods for the determination of some anticancer drugs in pharmaceutical and biological samples. Talanta 2021;229:122247. [PMID: 33838767 DOI: 10.1016/j.talanta.2021.122247] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 Dong S, Song C, Qi B, Jiang X, Liu L, Xu Y. Strongly preserved modules between cancer tissue and cell line contribute to drug resistance analysis across multiple cancer types. Genomics 2021;113:1026-36. [PMID: 33647440 DOI: 10.1016/j.ygeno.2021.02.015] [Reference Citation Analysis]
23 Rezende AA, Santos RS, Andrade LN, Amaral RG, Pereira MM, Bani C, Chen M, Priefer R, da Silva CF, de Albuquerque Júnior RLC, Souto EB, Severino P. Anti-Tumor Efficiency of Perillylalcohol/β-Cyclodextrin Inclusion Complexes in a Sarcoma S180-Induced Mice Model. Pharmaceutics 2021;13:245. [PMID: 33578857 DOI: 10.3390/pharmaceutics13020245] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
24 Quarti J, Torres DNM, Ferreira E, Vidal RS, Casanova F, Chiarini LB, Fialho E, Rumjanek VM. Selective Cytotoxicity of Piperine Over Multidrug Resistance Leukemic Cells. Molecules 2021;26:934. [PMID: 33578817 DOI: 10.3390/molecules26040934] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Mbaveng AT, Wamba BEN, Bitchagno GTM, Tankeo SB, Çelik İ, Atontsa BCK, Nkuété Lonfouo AH, Kuete V, Efferth T. Bioactivity of fractions and constituents of Piper capense fruits towards a broad panel of cancer cells. J Ethnopharmacol 2021;271:113884. [PMID: 33529639 DOI: 10.1016/j.jep.2021.113884] [Reference Citation Analysis]
26 Gu X, Guan M, Jiang C, Song Q, Li X, Sun N, Chen J, Qiu J. Assessment of Thiosemicarbazone-Containing Compounds as Potential Antileukemia Agents against P-gp Overexpressing Drug Resistant K562/A02 Cells. Chem Biodivers 2021;18:e2000775. [PMID: 33314614 DOI: 10.1002/cbdv.202000775] [Reference Citation Analysis]
27 Mbaveng AT, Chi GF, Bonsou IN, Ombito JO, Yeboah SO, Kuete V, Efferth T. Cytotoxic phytochemicals from the crude extract of Tetrapleura tetraptera fruits towards multi-factorial drug resistant cancer cells. J Ethnopharmacol 2021;267:113632. [PMID: 33253828 DOI: 10.1016/j.jep.2020.113632] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Mbaveng AT, Noulala CGT, Samba ARM, Tankeo SB, Abdelfatah S, Fotso GW, Happi EN, Ngadjui BT, Beng VP, Kuete V, Efferth T. The alkaloid, soyauxinium chloride, displays remarkable cytotoxic effects towards a panel of cancer cells, inducing apoptosis, ferroptosis and necroptosis. Chem Biol Interact 2021;333:109334. [PMID: 33245930 DOI: 10.1016/j.cbi.2020.109334] [Reference Citation Analysis]
29 Mahawar P, Wasson MK, Sharma MK, Jha CK, Mukherjee G, Vivekanandan P, Nagendran S. A Prelude to Biogermylene Chemistry*. Angew Chem Int Ed Engl 2020;59:21377-81. [PMID: 33462912 DOI: 10.1002/anie.202004551] [Reference Citation Analysis]
30 Savchenko RG, Nové M, Spengler G, Hunyadi A, Parfenova LV. In vitro adjuvant antitumor activity of various classes of semi-synthetic poststerone derivatives. Bioorg Chem 2021;106:104485. [PMID: 33261846 DOI: 10.1016/j.bioorg.2020.104485] [Reference Citation Analysis]
31 Xu D, Xu Z. Indole Alkaloids with Potential Anticancer Activity. CTMC 2020;20:1938-49. [DOI: 10.2174/1568026620666200622150325] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
32 Norouzi S, Yazdian Robati R, Ghandadi M, Abnous K, Behravan J, Mosaffa F. Comparative proteomics study of proteins involved in induction of higher rates of cell death in mitoxantrone-resistant breast cancer cells MCF-7/MX exposed to TNF-α. Iran J Basic Med Sci 2020;23:663-72. [PMID: 32742605 DOI: 10.22038/ijbms.2020.40029.9486] [Reference Citation Analysis]
33 Efferth T, Kadioglu O, Saeed MEM, Seo E, Mbaveng AT, Kuete V. Medicinal plants and phytochemicals against multidrug-resistant tumor cells expressing ABCB1, ABCG2, or ABCB5: a synopsis of 2 decades. Phytochem Rev 2021;20:7-53. [DOI: 10.1007/s11101-020-09703-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
34 Dawood M, Fleischer E, Klinger A, Bringmann G, Shan L, Efferth T. Inhibition of cell migration and induction of apoptosis by a novel class II histone deacetylase inhibitor, MCC2344. Pharmacol Res 2020;160:105076. [PMID: 32659428 DOI: 10.1016/j.phrs.2020.105076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
35 Domínguez-Martín EM, Tavares J, Rijo P, Díaz-Lanza AM. Zoopharmacology: A Way to Discover New Cancer Treatments. Biomolecules 2020;10:E817. [PMID: 32466543 DOI: 10.3390/biom10060817] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
36 Song X, Fan J, Liu L, Liu X, Gao F. Coumarin derivatives with anticancer activities: An update. Arch Pharm 2020;353:2000025. [DOI: 10.1002/ardp.202000025] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 7.5] [Reference Citation Analysis]
37 Jia Y, Wen X, Gong Y, Wang X. Current scenario of indole derivatives with potential anti-drug-resistant cancer activity. Eur J Med Chem 2020;200:112359. [PMID: 32531682 DOI: 10.1016/j.ejmech.2020.112359] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
38 Li W, Du Q, Li X, Zheng X, Lv F, Xi X, Huang G, Yang J, Liu S. Eriodictyol Inhibits Proliferation, Metastasis and Induces Apoptosis of Glioma Cells via PI3K/Akt/NF-κB Signaling Pathway. Front Pharmacol 2020;11:114. [PMID: 32158391 DOI: 10.3389/fphar.2020.00114] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
39 Tóth S, Szepesi Á, Tran-Nguyen VK, Sarkadi B, Német K, Falson P, Di Pietro A, Szakács G, Boumendjel A. Synthesis and Anticancer Cytotoxicity of Azaaurones Overcoming Multidrug Resistance. Molecules 2020;25:E764. [PMID: 32050702 DOI: 10.3390/molecules25030764] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
40 Dong Y, Liao H, Yu J, Fu H, Zhao, Gong K, Wang Q, Duan Y. Incorporation of drug efflux inhibitor and chemotherapeutic agent into an inorganic/organic platform for the effective treatment of multidrug resistant breast cancer. J Nanobiotechnology 2019;17:125. [PMID: 31870362 DOI: 10.1186/s12951-019-0559-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
41 Boulos JC, Rahama M, Hegazy MF, Efferth T. Shikonin derivatives for cancer prevention and therapy. Cancer Lett 2019;459:248-67. [PMID: 31132429 DOI: 10.1016/j.canlet.2019.04.033] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 9.0] [Reference Citation Analysis]